STYLAGE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Stylage Bi-Soft XL
Stylage Bi-Soft XL is a volumising filler for restoring and creating facial volume. It targets age-related volume loss and structural contouring of the temples, cheeks, cheekbones, jawline, and chin.
Stylage Bi-Soft XL is a cross-linked hyaluronic acid dermal filler produced by Laboratoires VIVACY in France, created for facial remodelling and the restoration or augmentation of facial volume. It is commonly chosen by clinics, aesthetic physicians and dermatologists to restore volume loss or displacement in the cheeks, cheekbones and temples. The gel contains cross-linked hyaluronic acid at 26 mg/mL in a phosphate buffer enriched with mannitol (35 mg/g), is injected into the deep dermis or subcutaneously, is supplied in the patented Bi-SOFT injection system, and is intended for professional use by qualified practitioners only.
Key Benefits of Stylage Bi-Soft XL
- Restores volume loss or displacement, and is perfectly adapted for midface remodelling
- Contains cross-linked hyaluronic acid at 26 mg/mL in a mannitol-enriched phosphate buffer (35 mg/g)
- Dynamic and smooth projection capacity, with excellent tissue integration and high cohesivity
- Supplied without anaesthetic; Stylage Bi-Soft XL Lidocaine is the anaesthetic-containing option
- Patented Bi-SOFT injection system - VIVACY reports 97% of practitioners extremely satisfied with it
- CE-marked Class III medical device (CE 0344), made in France
Indications and Professional Use
Main indications
- Restoration or augmentation of facial volume
- Correction of age-related volume loss
- Restoration of volume loss or displacement
- Midface remodelling
Professional use
Stylage Bi-Soft XL is intended for administration by qualified medical practitioners trained in volumising dermal filler techniques, using aseptic technique. The manufacturer states that injection must be administered by a legally authorised practitioner trained in implant injection techniques, and that the Instructions for Use must be read carefully before use. VIVACY specifies deep injection into the dermis or the subcutaneous plane. This reference is supplied without an incorporated anaesthetic, so practitioners who require anaesthetic support must either apply topical anaesthesia or select the separate Stylage Bi-Soft XL Lidocaine reference. Consult the Instructions for Use for contraindications and possible side effects. Injection technique and volume per treatment area are determined by the practitioner in accordance with the Instructions for Use.
Treatment areas
- Cheeks
- Cheekbones
- Temples
Patient profile
Suitable for adult patients presenting age-related facial volume loss, or facial sagging associated with volume loss, as assessed by a qualified practitioner. Because this is a volumising gel placed deeply into the dermis or subcutaneously, anatomical assessment and treatment planning are led by the practitioner. This reference contains no anaesthetic, so patient comfort management is planned separately. The product is a Class III medical device (CE 0344).
How Stylage Bi-Soft XL Works
The Stylage XL gel is a monophasic cross-linked hyaluronic acid volumiser that restores or creates facial volume once placed in deeper tissue, lifting and supporting areas that have lost structure with age. The phosphate buffer is enriched with mannitol, which is itself the antioxidant - VIVACY credits mannitol with scavenging oxygen-free radicals, a thermal stabilising effect and protecting the hyaluronic acid against degradation; there is no separate antioxidants ingredient. The patented Bi-SOFT syringe system contributes on the delivery side rather than the gel side: VIVACY describes it as reducing the sensation of injection force, adding grip and stability, and improving readability of the injected volume, which matters when placing a volumiser. This makes it suitable for facial remodelling and midface volume restoration rather than the correction of fine surface lines.
Why Order From Allpara
Allpara offers genuine, verified STYLAGE products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
How does Stylage Bi-Soft XL differ from Stylage Bi-Soft XXL?
Stylage XL is 26 mg/mL and is adapted for midface remodelling, restoring volume loss or displacement in the cheeks, cheekbones and temples. XXL is 21 mg/mL but rheologically firmer, for sharp restructuring of the chin, jawline, mandibular angle and cheekbones. XXL also uses mepivacaine rather than lidocaine where an anaesthetic presentation is supplied.
Does Stylage Bi-Soft XL contain an anaesthetic?
No. This reference is supplied without anaesthetic. VIVACY also supplies STYLAGE XL with lidocaine hydrochloride monohydrate 0.3% w/w, sold here as Stylage Bi-Soft XL Lidocaine.
Which side effects does VIVACY list?
As a non-exhaustive list: inflammation, redness, swelling, pain, erythema, induration, nodules, colouration or discolouration, and bruising. Serious side effects should be reported without delay to Laboratoires VIVACY and to the national health authority of the country in which the patient is established.
Customer Reviews
More from Laboratoires VIVACY
Clinic alternatives
Pick up where you left off
Stylage Bi-Soft XL is a cross-linked hyaluronic acid dermal filler produced by Laboratoires VIVACY in France, created for facial remodelling and the restoration or augmentation of facial volume. It is commonly chosen by clinics, aesthetic physicians and dermatologists to restore volume loss or displacement in the cheeks, cheekbones and temples. The gel contains cross-linked hyaluronic acid at 26 mg/mL in a phosphate buffer enriched with mannitol (35 mg/g), is injected into the deep dermis or subcutaneously, is supplied in the patented Bi-SOFT injection system, and is intended for professional use by qualified practitioners only.
Key Benefits of Stylage Bi-Soft XL
- Restores volume loss or displacement, and is perfectly adapted for midface remodelling
- Contains cross-linked hyaluronic acid at 26 mg/mL in a mannitol-enriched phosphate buffer (35 mg/g)
- Dynamic and smooth projection capacity, with excellent tissue integration and high cohesivity
- Supplied without anaesthetic; Stylage Bi-Soft XL Lidocaine is the anaesthetic-containing option
- Patented Bi-SOFT injection system - VIVACY reports 97% of practitioners extremely satisfied with it
- CE-marked Class III medical device (CE 0344), made in France
Indications and Professional Use
Main indications
- Restoration or augmentation of facial volume
- Correction of age-related volume loss
- Restoration of volume loss or displacement
- Midface remodelling
Professional use
Stylage Bi-Soft XL is intended for administration by qualified medical practitioners trained in volumising dermal filler techniques, using aseptic technique. The manufacturer states that injection must be administered by a legally authorised practitioner trained in implant injection techniques, and that the Instructions for Use must be read carefully before use. VIVACY specifies deep injection into the dermis or the subcutaneous plane. This reference is supplied without an incorporated anaesthetic, so practitioners who require anaesthetic support must either apply topical anaesthesia or select the separate Stylage Bi-Soft XL Lidocaine reference. Consult the Instructions for Use for contraindications and possible side effects. Injection technique and volume per treatment area are determined by the practitioner in accordance with the Instructions for Use.
Treatment areas
- Cheeks
- Cheekbones
- Temples
Patient profile
Suitable for adult patients presenting age-related facial volume loss, or facial sagging associated with volume loss, as assessed by a qualified practitioner. Because this is a volumising gel placed deeply into the dermis or subcutaneously, anatomical assessment and treatment planning are led by the practitioner. This reference contains no anaesthetic, so patient comfort management is planned separately. The product is a Class III medical device (CE 0344).
How Stylage Bi-Soft XL Works
The Stylage XL gel is a monophasic cross-linked hyaluronic acid volumiser that restores or creates facial volume once placed in deeper tissue, lifting and supporting areas that have lost structure with age. The phosphate buffer is enriched with mannitol, which is itself the antioxidant - VIVACY credits mannitol with scavenging oxygen-free radicals, a thermal stabilising effect and protecting the hyaluronic acid against degradation; there is no separate antioxidants ingredient. The patented Bi-SOFT syringe system contributes on the delivery side rather than the gel side: VIVACY describes it as reducing the sensation of injection force, adding grip and stability, and improving readability of the injected volume, which matters when placing a volumiser. This makes it suitable for facial remodelling and midface volume restoration rather than the correction of fine surface lines.
Why Order From Allpara
Allpara offers genuine, verified STYLAGE products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
How does Stylage Bi-Soft XL differ from Stylage Bi-Soft XXL?
Stylage XL is 26 mg/mL and is adapted for midface remodelling, restoring volume loss or displacement in the cheeks, cheekbones and temples. XXL is 21 mg/mL but rheologically firmer, for sharp restructuring of the chin, jawline, mandibular angle and cheekbones. XXL also uses mepivacaine rather than lidocaine where an anaesthetic presentation is supplied.
Does Stylage Bi-Soft XL contain an anaesthetic?
No. This reference is supplied without anaesthetic. VIVACY also supplies STYLAGE XL with lidocaine hydrochloride monohydrate 0.3% w/w, sold here as Stylage Bi-Soft XL Lidocaine.
Which side effects does VIVACY list?
As a non-exhaustive list: inflammation, redness, swelling, pain, erythema, induration, nodules, colouration or discolouration, and bruising. Serious side effects should be reported without delay to Laboratoires VIVACY and to the national health authority of the country in which the patient is established.